Transmedics Group Equity 2024

Transmedics Group Aktienanalyse

What does Transmedics Group do?

Transmedics Group Inc is a company dedicated to the development and manufacturing of medical devices for organ transplantation. The company was founded in 1998 and is headquartered in Andover, Massachusetts, USA. Transmedics' business model is based on offering a unique and innovative technology for organ preservation during transport from donor to recipient. The patented Organ Care System (OCS) platform includes a range of state-of-the-art medical devices specifically designed for organ transport. Transmedics' Organ Care System includes three main devices: OCS Heart, OCS Lung, and OCS Liver. Each device is tailored for organ preparation and transport, providing individualized support based on the specific requirements of each organ and different transfer protocols. The OCS technology uses hypothermic (cold) perfusion to preserve the organ during transport. By continuously monitoring and supporting the organ's physiological functions, the OCS system can improve the survival rate of donor organs while reducing the time spent outside the body. Transmedics also offers comprehensive services, including the availability of OCS devices and qualified personnel to provide support throughout the transplantation process. Transmedics' customers include leading transplant centers and hospitals worldwide. The company works closely with these customers to ensure that its OCS devices meet the specific requirements of each transplantation program and help them achieve more successful transplantations. Transmedics' history is marked by a passion for improving transplantation medicine and saving lives through the provision of advanced technologies and solutions. The company has made significant progress in recent years and has experienced strong growth in all areas. Transmedics has also received a number of awards and recognition for its commitment to improving transplantation medicine. For example, in 2020, the company received the Red Herring Top 100 Global Award and was recognized for the seventh consecutive year as one of the fastest-growing companies by Deloitte. Overall, Transmedics is a leading provider of innovative medical devices for transplantation medicine. Through its organic technology and comprehensive service, the company supports transplant centers and hospitals worldwide in performing more successful transplantations and saving patients' lives. Transmedics Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Transmedics Group's Equity

Transmedics Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Transmedics Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Transmedics Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Transmedics Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Transmedics Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Transmedics Group Stock

What is the equity of Transmedics Group this year?

Transmedics Group has equity of 137.2 M USD this year.

What was the equity of Transmedics Group compared to the previous year?

The equity of Transmedics Group has increased/decreased by -26.79% decreased compared to the previous year.

What impact does a high equity have on investors of Transmedics Group?

A high equity is advantageous for investors of Transmedics Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Transmedics Group?

A low equity can be a risk for investors of Transmedics Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Transmedics Group affect the company?

An increase in equity of Transmedics Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Transmedics Group affect the company?

A reduction in equity of Transmedics Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Transmedics Group?

Some factors that can affect the equity of Transmedics Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Transmedics Group so important for investors?

The equity of Transmedics Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Transmedics Group take to change the equity?

To change equity, Transmedics Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Transmedics Group pay?

Over the past 12 months, Transmedics Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Transmedics Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Transmedics Group?

The current dividend yield of Transmedics Group is .

When does Transmedics Group pay dividends?

Transmedics Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Transmedics Group?

Transmedics Group paid dividends every year for the past 0 years.

What is the dividend of Transmedics Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Transmedics Group located?

Transmedics Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Transmedics Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Transmedics Group from 6/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did Transmedics Group pay the last dividend?

The last dividend was paid out on 6/7/2024.

What was the dividend of Transmedics Group in the year 2023?

In the year 2023, Transmedics Group distributed 0 USD as dividends.

In which currency does Transmedics Group pay out the dividend?

The dividends of Transmedics Group are distributed in USD.